The primary objective of this study was to compare the occurrence of acute kidney injury (AKI) in patients with cystic fibrosis (CF) receiving intravenous (IV) vancomycin monitored through single serum… Click to show full abstract
The primary objective of this study was to compare the occurrence of acute kidney injury (AKI) in patients with cystic fibrosis (CF) receiving intravenous (IV) vancomycin monitored through single serum trough concentrations and two‐point estimated area under the curve (AUC). Time to next exacerbation and return to baseline lung function were also assessed.
               
Click one of the above tabs to view related content.